Nikhil Dhingra, Emma Guttman-Yassky 

Slides:



Advertisements
Similar presentations
IL-17A as an Inducer for Th2 Immune Responses in Murine Atopic Dermatitis Models  Saeko Nakajima, Akihiko Kitoh, Gyohei Egawa, Yohei Natsuaki, Satoshi.
Advertisements

Natalija Novak, MD  Journal of Allergy and Clinical Immunology 
Tomotaka Mabuchi, Samuel T. Hwang  Journal of Investigative Dermatology 
Donald Y.M. Leung, MD, PhD, Emma Guttman-Yassky, MD, PhD 
Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis  Mayte Suárez-Fariñas, PhD,
SERPINB3/B4 Contributes to Early Inflammation and Barrier Dysfunction in an Experimental Murine Model of Atopic Dermatitis  Umasundari Sivaprasad, Kayla.
Atopic dermatitis results in intrinsic barrier and immune abnormalities: Implications for contact dermatitis  Julia K. Gittler, BA, James G. Krueger,
Stressing the Steroids in Skin: Paradox or Fine-Tuning?
Gene Profiling of Narrowband UVB–Induced Skin Injury Defines Cellular and Molecular Innate Immune Responses  Milène Kennedy Crispin, Judilyn Fuentes-Duculan,
IL-17: A Key Player in the P. acnes Inflammatory Cascade?
Progressive activation of TH2/TH22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis  Julia K. Gittler, BA,
Atsunari Tsuchisaka, Minao Furumura, Takashi Hashimoto 
Therapeutic pipeline for atopic dermatitis: End of the drought?
Shinji Noda, MD, PhD, James G
Genes Involved in Stem Cell Fate Decisions and Commitment to Differentiation Play a Role in Skin Disease  Kimberly A. Honeycutt, Maranke I. Koster, Dennis.
The Multitasking Organ: Recent Insights into Skin Immune Function
IL-17A as an Inducer for Th2 Immune Responses in Murine Atopic Dermatitis Models  Saeko Nakajima, Akihiko Kitoh, Gyohei Egawa, Yohei Natsuaki, Satoshi.
Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response  Suzanne Tintle, BS, Avner Shemer, MD, Mayte Suárez-Fariñas,
IL-22–producing “T22” T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17–producing TH17 T cells  Kristine E. Nograles, MD,
An Unexpected Role: UVA-Induced Release of Nitric Oxide from Skin May Have Unexpected Health Benefits  Gary M. Halliday, Scott N. Byrne  Journal of Investigative.
Transcriptional Profiling after Lipid Raft Disruption in Keratinocytes Identifies Critical Mediators of Atopic Dermatitis Pathways  Conny Mathay, Michael.
Mechanisms of Action of Etanercept in Psoriasis
The Multitasking Organ: Recent Insights into Skin Immune Function
PXR: A New Player in Atopic Dermatitis
EGFR (Trans)activation Mediates IL-8 and Distinct Human Antimicrobial Peptide and Protein Production following Skin Injury  Amanda S. Büchau  Journal.
Crosstalk between Keratinocytes and T Cells in a 3D Microenvironment: A Model to Study Inflammatory Skin Diseases  Ellen H. van den Bogaard, Geuranne.
One Remarkable Molecule: Filaggrin
Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid Conditions  Batya B. Davidovici, Naveed Sattar,
Recapitulating Atopic Dermatitis in Three Dimensions: Cross Talk between Keratinocytes and Nerve Fibers  Carlo Pincelli, Martin Steinhoff  Journal of.
GRowing an Epidermal Tumor
Modeling Atopic Dermatitis with Increasingly Complex Mouse Models
Docosahexaenoic Acid Alleviates Atopic Dermatitis in Mice by Generating T Regulatory Cells and M2 Macrophages  Karyn A. Haitz, Niroshana Anandasabapathy 
Novel concepts of prevention and treatment of atopic dermatitis through barrier and immune manipulations with implications for the atopic march  Tali.
Manipulated Microenvironment in Human Papilloma Virus–Infected Epithelial Cells: Is the CD40–CD154 Pathway Beneficial for Host or Virus?  Takatoshi Shimauchi,
Tomotaka Mabuchi, Samuel T. Hwang  Journal of Investigative Dermatology 
CD8 T Cells and IFN-γ Emerge as Critical Players for Psoriasis in a Novel Model of Mouse Psoriasiform Skin Inflammation  Paola Di Meglio, João H. Duarte 
The Immunologic Revolution: Photoimmunology
The Role of Chronic Inflammation in Cutaneous Fibrosis: Fibroblast Growth Factor Receptor Deficiency in Keratinocytes as an Example  Michael Meyer, Anna-Katharina.
Mechanisms of Contact Sensitization Offer Insights into the Role of Barrier Defects vs. Intrinsic Immune Abnormalities as Drivers of Atopic Dermatitis 
Volume 37, Issue 1, Pages 5-7 (July 2012)
Chemokine Receptors in T-Cell-Mediated Diseases of the Skin
Skin Barrier Disruption: A Requirement for Allergen Sensitization?
Clinical Snippets Journal of Investigative Dermatology
Minutes of the Board of Directors Meeting
Peter M. Elias, Martin Steinhoff  Journal of Investigative Dermatology 
A Role for Th17 Cells in the Immunopathogenesis of Atopic Dermatitis?
MyD88 Contributes to Staphylococcal Enterotoxin B-Triggered Atopic Dermatitis-Like Skin Inflammation in Mice  Sonja Faßbender, Friederike V. Opitz, Sarah.
Journal of Investigative Dermatology
Apocrine Gland–Rich Skin Has a Non-Inflammatory IL-17–Related Immune Milieu, that Turns to Inflammatory IL-17–Mediated Disease in Hidradenitis Suppurativa 
A New “Immunological” Role for Adipocytes in Obesity
David Quigley  Journal of Investigative Dermatology 
Revisiting the role of B cells in skin immune surveillance
The Adverse Effect of IFN Gamma on Stratum Corneum Structure and Function in Psoriasis and Atopic Dermatitis  Kenneth R. Feingold  Journal of Investigative.
Michael C. Velarde  Journal of Investigative Dermatology 
Integrative Responses to IL-17 and TNF-α in Human Keratinocytes Account for Key Inflammatory Pathogenic Circuits in Psoriasis  Andrea Chiricozzi, Emma.
Society for Investigative Dermatology 2010 Meeting Minutes
Sam T. Hwang  Journal of Investigative Dermatology 
David A. Martin, Jennifer E
25 Years of Epidermal Stem Cell Research
Standard Treatment: The Role of Antihistamines
Donald Y.M. Leung, MD, PhD  Journal of Allergy and Clinical Immunology 
Defining the Antigen Determinant for T-Cell-Mediated Contact Dermatitis Using p- Phenylenediamine: A Gateway to Chemical Immunology  Graham Elliott, Pranab.
The skin as an immune organ: Tolerance versus effector responses and applications to food allergy and hypersensitivity reactions  Emma Guttman-Yassky,
Journal of Investigative Dermatology
Chemokines: Key Players in Innate and Adaptive Immunity
Sorting Out the p63 Signaling Network
DLX3-Dependent STAT3 Signaling in Keratinocytes Regulates Skin Immune Homeostasis  Shreya Bhattacharya, Jin-Chul Kim, Youichi Ogawa, Gaku Nakato, Veronica.
Rosanna Marsella, Giampiero Girolomoni 
Innate Immunity Stimulates Permeability Barrier Homeostasis
Contrasting pathogenesis of atopic dermatitis and psoriasis—Part II: Immune cell subsets and therapeutic concepts  Emma Guttman-Yassky, MD, PhD, Kristine.
Presentation transcript:

A Possible Role for IL-17A in Establishing Th2 Inflammation in Murine Models of Atopic Dermatitis  Nikhil Dhingra, Emma Guttman-Yassky  Journal of Investigative Dermatology  Volume 134, Issue 8, Pages 2071-2074 (August 2014) DOI: 10.1038/jid.2014.141 Copyright © 2014 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 1 A schematic illustration of the initiation of acute atopic dermatitis (AD) and progression to chronic skin lesions. Non-lesional AD skin lesions show some immune infiltrates that produce inflammatory mediators, which may contribute to a defective epidermal barrier. Barrier defects lead to penetration by epicutaneous antigens that encounter Langerhans cells in the epidermis and dermal dendritic cells (DCs) in the dermis, inducing marked immune activation and recruitment of inflammatory cells in acute AD lesions. The finding by Nakajima et al. (2014) regarding the role of IL-17A may potentially bridge the gap between non-lesional skin following antigen penetration and onset of acute disease, where T helper type 17 (Th17) T cells have been identified in limited quantities. This relatively small Th17 activity could potentially lead to the marked activation of Th2 axis in acute disease onset; Th22 activity also increases. A progressive activation of the Th2, Th22, and Th1 pathways is characteristic of the chronic stage of AD; Th17 activity remains constant from acute disease. Cytokines (i.e., IL-4 and IL-13) and chemokines (i.e., chemokine (C-C motif) ligand (CCL)17, CCL18, CCL19, chemokine (CXC motif) ligand (CXCL)9, CXCL10, and CXCL11) produced by various T cells and DCs induce further activation and recruitment of additional immune cells. With the onset of acute disease, Th22 cells release IL-22, which induces epidermal hyperplasia and, synergistically with the Th17 cytokine IL-17, drives an abrupt increase in a subset of terminal differentiation genes, specifically the S100A7, S100A8, and S100A9 proteins. The increases in these barrier proteins contrast with the uniformly disrupted epidermal differentiation gene products (e.g., filaggrin, loricrin, and corneodesmosin) throughout non-lesional, acute, and chronic AD skin. The Th2 and Th22 cytokines contribute to inhibition of the terminal differentiation proteins. IL-31 is abruptly upregulated in acute disease, potentially reflecting its role as an itch mediator in patients with AD. Figure and legend adapted and modified from Gittler et al. (2012) with permission from Elsevier/RightsLink. Journal of Investigative Dermatology 2014 134, 2071-2074DOI: (10.1038/jid.2014.141) Copyright © 2014 The Society for Investigative Dermatology, Inc Terms and Conditions

Journal of Investigative Dermatology 2014 134, 2071-2074DOI: (10 Journal of Investigative Dermatology 2014 134, 2071-2074DOI: (10.1038/jid.2014.141) Copyright © 2014 The Society for Investigative Dermatology, Inc Terms and Conditions